208
Views
14
CrossRef citations to date
0
Altmetric
Research Article

IMA and IMAR in serum and saliva of preeclampsia – a preliminary study

, , , &

References

  • Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308:1592–4
  • Walsh SW. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrinol 1998;16:93–104
  • Watanabe K, Mori T, Iwasaki A, et al. Increased oxygen free radical production during pregnancy may impair vascular reactivity in preeclamptic women. Hypertens Res 2013;36:356–60
  • Rani N, Dhingra R, Arya DS, et al. Role of oxidative stress markers and antioxidants in the placenta of preeclamptic patients. J Obstet Gynaecol Res 2010;36:1189–94
  • Bourdon E, Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal 2001;3:293–311
  • Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan Med Bull 1990;37:57–84
  • Grzebyk E, Piwowar A. Glycoxidative modification of albumin in medical research. Pol Merkur Lekarski 2013;34:239–42
  • Christenson RH, Duh SH, Sanhai WR, et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 2001;47:464–70
  • Gafsou B, Lefèvre G, Hennache B, et al. Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia? Hypertens Pregnancy 2010;29:101–11
  • Hofman LF. Human saliva as a diagnostic specimen. J Nutr 2001;131:1621S–5S
  • Bentur L, Mansour Y, Brik R, et al. Salivary oxidative stress in children during acute asthmatic attack and during remission. Respir Med 2006;100:1195–201
  • Dodds MW, Yeh CK, Johnson DA. Salivary alterations in type 2 (non-insulin-dependent) diabetes mellitus and hypertension. Community Dent Oral Epidemiol 2000;28:373–81
  • Komatsu T, Duckyoung Y, Ito A, et al. Increased oxidative stress biomarkers in the saliva of Down syndrome patients. Arch Oral Biol 2013;58:1246–50
  • Toker A, Aribas A, Yerlikaya FH, et al. Serum and saliva levels of ischemia-modified albumin in patients with acute myocardial infarction. J Clin Lab Anal 2013;27:99–104
  • ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 33, January 2002. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;99:159–67
  • Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med 2000;19:311–15
  • Varley RH, Gowenlock AH. Proteins. Pract Clin Biochem 1953;1:545–7
  • Taverna M, Marie AL, Mira JP, Guidet B. Specific antioxidant properties of human serum albumin. Ann Intensive Care 2013;3:4. doi: 10.1186/2110-5820-3-4
  • Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes – review and clinical implications. Clin Chem Lab Med 2011;49:177–84
  • Albarello K, dos Santos GA, Bochi GV, et al. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis. Clin Biochem 2012;45:450–4
  • Wu AH, Morris DL, Fletcher DR, et al. Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol 2001;1:147–51
  • Guven S, Alver A, Mentese A, et al. The novel ischemia marker ‘ischemia-modified albumin’ is increased in normal pregnancies. Acta Obstet Gynecol Scand 2009;88:479–82
  • Papageorghiou AT, Prefumo F, Leslie K, et al. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin. Hum Reprod 2008;23:803–6
  • Ustün Y, Engin-Ustün Y, Oztürk O, et al. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med 2011;24:418–21
  • Sinha MK, Vazquez JM, Calvino R, et al. Effects of balloon occlusion during percutaneous coronary intervention on circulating ischemia modified albumin and transmyocardial lactate extraction. Heart 2006;92:1852–3
  • Clavant SP, Sastra SA, Osicka TM, Comper WD. The analysis and characterisation of immuno-unreactive urinary albumin in healthy volunteers. Clin Biochem 2006;39:143–51
  • Holt JL, Mangos GJ, Brown MA. Measuring protein excretion in pregnancy. Nephrology (Carlton) 2007;12:425–30
  • Canakci V, Yildirim A, Canakci CF, et al. Total antioxidant capacity and antioxidant enzymes in serum, saliva, and gingival cervicular fluid of preeclamptic women with and without periodontal disease. J Periodontol 2007;78:1602–11
  • Van Rijn BB, Franx A, Sikkema JM, et al. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy 2008;27:159–67
  • Hung TH, Burton GJ. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006;45:189–200
  • Fujimaki A, Watanabe K, Mori T, et al. Placental oxidative DNA damage and its repair in preeclamptic women with fetal growth restriction. Placenta 2011;32:367–72
  • Gugliucci A, Hermo R, Monroy C, et al. Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries. Clin Chim Acta 2005;362:155–60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.